Targeting the MDM2/Caspase-3/GSDME axis: apatinib and cinobufagin synergistically induce pyroptosis to suppress gastric cancer progression.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.